MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2012.01.003

Медицинская библиотека · American heart journal · 2012

Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study.

Karthikeyan Ganesan, Zühlke Liesl, Engel Mark, Rangarajan Sumathy, Yusuf Salim, Teo Koon, Mayosi Bongani M

СтатьяResearch Support, American Recovery and Reinvestment ActПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Rheumatic heart disease (RHD) is the principal cause of valvular heart disease-related mortality and morbidity in low- and middle-income countries. The disease predominantly affects children and young adults. It is estimated that RHD may potentially be responsible for 1.4 million deaths annually worldwide and 7.5% of all strokes occurring in developing countries. Despite the staggering global burden, there are no contemporary data documenting the presentation, clinical course, complications, and treatment practices among patients with RHD.

METHODS

The REMEDY study is a prospective, international, multicenter, hospital-based registry planned in 2 phases: the vanguard phase involving centers in Africa and India will enroll 3,000 participants with RHD over a 1-year period. We will document clinical and echocardiographic characteristics of patients at presentation. Over a 2-year follow-up, we will document disease progression and treatment practices with particular reference to adherence to secondary prophylaxis and oral anticoagulation regimens. With 3,000 patients, we will be able to reliably determine the incidence of all-cause mortality, worsening heart failure requiring hospitalization, systemic embolism (including stroke), and major bleeding individually among all participants. We will identify barriers to care in a subgroup of 500 patients.

CONCLUSION

The REMEDY study will provide comprehensive, contemporary data on patients with RHD and will help in the development of strategies to prevent and manage RHD and its complications.

Для цитирования: Karthikeyan Ganesan, Zühlke Liesl, Engel Mark, Rangarajan Sumathy, Yusuf Salim, Teo Koon, Mayosi Bongani M. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study.. American heart journal. 2012. DOI: 10.1016/j.ahj.2012.01.003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.